Scott Sultan, MD, FACG

About the researcher:



Dr. Keith Sultan graduated with a BS in Mathematics from Union College, New York and an MD from State University of New York, School of Medicine at Stony Brook. He completed his residency in internal medicine from Lenox Hill Hospital and received postdoctoral training in gastroenterology from Lenox Hill Hospital.

Dr. Sultan has been an attending physician in the Division of Gastroenterology, Hepatology and Nutrition since 2009, and is an Assistant Professor of Medicine at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. In addition, Dr. Sultan has multiple Medical Attending appointments throughout the hospitals within the Northwell Health. Dr. Sultan’s professional memberships include the American Gastroenterological Association and the Crohn’s and Colitis Foundation of America. He is a fellow of the American College of Gastroenterology and serves on the College’s Archives Committee.

Research focus:

Research interests

Inflammatory Bowel Disease (IBD)
Investigating the relationship between IBD outcomes and opiate pain medication usage
IDB patient registry

Research training opportunities for residents and fellows:

  • Investigating the correlation between Irritable Bowel Disease and opiate pain medication usage
  • Developing an IBD patient registry within Nothwell Health


State University of New York, School of Medicine at Stony Brook

Degree: MD

Lenox Hill Hospital, St. Barnabas Medical Center

Degree: Residency

Lenox Hill Hospital

Degree: Fellowship


  1. Histological healing favors lower risk of colon carcinoma in extensive ulcerative colitis. Korelitz BI, Sultan K, Kothari M, Arapos L, Schneider J, Panagopoulos G. World J Gastroenterol. 2014 May 7;20(17):4980-6. doi: 10.3748/wjg.v20.i17.4980. PMID: 24803809 
  2. Venous Thromboembolism Risk in Patients With Inflammatory Bowel Disease: Defining the Benefits of Pharmacologic Prophylaxis.Sultan K, Brun A, Spyropoulos AC. Clin Gastroenterol Hepatol. 2014 Apr 1. pii: S1542-3565(14)00475-3. doi: 10.1016/j.cgh.2014.03.025. PMID: 24703865
  3. Resident knowledge of colorectal cancer screening assessed by web-based survey. Akerman S, Aronson SL, Cerulli MA, Akerman M,Sultan K. J Clin Med Res. 2014 Apr;6(2):120-6. doi: 10.14740/jocmr1610w. Epub 2014 Feb 6. PMID: 24578753 
  4. Evolving concepts: how diet and the intestinal microbiome act as modulators of breast malignancy. Shapira I, Sultan K, Lee A, Taioli E. ISRN Oncol. 2013 Sep 25;2013:693920. doi: 10.1155/2013/693920. Review. PMID: 24187630
  5. Prognosis of lymphoma in patients following treatment with 6-mercaptopurine/azathioprine for inflammatory bowel disease. Sultan K, Korelitz BI, Present D, Katz S, Sunday S, Shapira I. Inflamm Bowel Dis. 2012 Oct;18(10):1855-8. doi: 10.1002/ibd.22866. Epub 2012 Jan 12. PMID: 22241664